한글목차

세계의 오가노이드 시장은 2018년에 13억 605만 달러로 평가되며, 2023년까지 20.00% 이상의 CAGR로 성장했습니다.

맞춤형 의료에 대한 수요의 증가

맞춤형 의료에 대한 수요 증가는 오가노이드 시장의 성장을 가속했습니다. 맞춤의료는 정밀의료 또는 개인맞춤의료라고도 불리며, 환자 개개인의 특성에 맞는 치료와 개입을 목표로 하는 의료 접근법입니다. 환자 개개인의 특성을 재현할 수 있는 오가노이드는 특정 유전자 프로파일과 질병 특성에 맞는 치료를 위한 필수적인 툴이 되고 있습니다. 이러한 수요의 급증으로 약물 검사, 질병 모델링, 정밀의료 용도에서 오가노이드의 중요성과 채택이 증가하고 있습니다. 예를 들어 2022년 10월 미국 기반의 과학자, 환자 및 의료 서비스 프로바이더를 대표하는 단체인 Personalized Medicine Coalition은 여러 유형의 암, 유전적 희귀질환, 다양한 만성질환 및 감염성 질환을 앓고 있는 사람들을 위해 75,000개 이상의 유전자 검사 제품 및 300개 이상의 이상의 유전자 검사 제품과 300개 이상의 개인맞춤형 의약품이 시장에 나와 있는 것으로 추정하고 있습니다. 또한 개인맞춤형 의료를 옹호하는 미국 개인맞춤의료연합(PMC)에 따르면 2022년에는 미국 식품의약국(FDA) 신약 승인의 34%를 개인맞춤형 의약품이 차지할 것으로 추정되며, 지난 8년 동안 개인맞춤형 의약품은 승인 건수의 25% 이상을 차지했습니다. 따라서 맞춤형 의료에 대한 수요 증가는 지난 기간 중 유기체 시장의 성장을 지원했습니다.

목차

제1장 주요 요약

제2장 목차

제3장 표 리스트

제4장 도표 리스트

제5장 리포트 구성

제6장 시장의 특징

• 일반적인 시장의 정의
• 개요
• 오가노이드 시장 정의와 세분화
• 시장 세분화 : 제품별
  • 간 오가노이드
  • 대장 오가노이드
  • 장관 오가노이드
  • 기타
• 시장 세분화 : 용도별
  • 발생생물학
  • 감염증의 병리학
  • 재생의료
  • 약물 독성과 유효성 시험
  • Drug Discovery와 맞춤형 의료
  • 기타
• 시장 세분화 : 최종 용도 산업별
  • 병원으로 진단 센터
  • 바이오의약품 기업
  • 학술기관·연구기관
  • 임상시험수탁기관(CRO)
• 시장 세분화 : 유래별
  • 다능성 줄기세포
  • 장기 특이적 성체 줄기세포

제7장 주요 시장 동향

• 바이오의약품 조사를 위한 오가노이드 솔루션에 초점을 맞추고, 솔루션을 확대
• 특수 3D 세포 모델의 작성을 위한 생명과학 조사의 진보
• 심장 안전성 시험의 개선을 향한 심장 오가노이드 기반 키트의 개발
• 차세대 오가노이드 기술의 진보를 향한 전략적 파트너십과 협업
• 하이스루풋(High throughput) 애플리케이션용 커스텀 오가노이드 라인 서비스에 주력
• 오가노이드와 세포 채취를 신속화하기 위한 3D 세포배양 기술의 채택 증가

제8장 오가노이드 시장 : 거시경제 시나리오

• COVID-19의 영향 : 오가노이드 시장
• 우크라이나 전쟁의 영향 : 오가노이드 시장
• 고인플레이션의 영향 : 오가노이드 시장

제9장 세계 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018-2023
  • 시장 촉진요인, 2018-2023
  • 시장 억제요인, 2018-2023
• 시장 성장 예측, 2023-2028, 2033F
  • 시장 촉진요인, 2023-2028
  • 시장 억제요인, 2023-2028

제10장 세계의 오가노이드 시장 : 세분화

• 세계의 오가노이드 시장 : 제품별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 오가노이드 시장 : 용도별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 오가노이드 시장 : 최종 용도 산업별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 오가노이드 시장 : 유래별, 실적과 예측, 2018-2023, 2028F, 2033F

제11장 오가노이드 시장 : 지역·국가별 분석

• 세계의 오가노이드 시장 : 지역별, 실적과 예측, 2018-2023, 2028F, 2033F
• 세계의 오가노이드 시장 : 국가별, 실적과 예측, 2018-2023, 2028F, 2033F

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 구도와 기업 개요

• 기업 개요
• Thermo Fisher Scientific Inc
• Carl Zeiss AG
• Corning Incorporated
• Lonza Group Ltd
• STEMCELL Technologies Inc

제20장 경쟁 벤치마킹

제21장 경쟁 대시보드

제22장 주요 합병과 인수

• Axosim Acquired The Microbrain-Associated Assets Of Vyant Bio's Stemonix Subsidiary
• Bruker Corporation Acquired Acquifer Imaging
• Molecular Devices Acquired Cellesce
• Crown Bioscience International Acquired OcellO

제23장 기회와 전략

• 세계의 오가노이드 시장 : 새로운 기회를 제공하는 국가
• 세계의 오가노이드 시장 : 새로운 기회를 제공하는 부문
• 세계의 오가노이드 시장 : 성장 전략

제24장 오가노이드 시장 : 결론과 제안

• 결론
• 제안

제25장 부록

영문목차

Organoids are three-dimensional cell cultures that mimic the structural and functional characteristics of real organs. These miniature, simplified versions of organs are grown from stem cells in a laboratory environment to replicate some of the complex biological structures and processes of their full-sized counterparts.

The organoids market consists of sales, by entities (organizations, sole traders and partnerships), of organoids products that are a revolutionary tool in modern biomedical research and medicine, enabling scientists and doctors to study human development, disease progression and drug responses in a controlled and replicable way.

The global organoids market was valued at $1,306.05 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 20.00%.

Increase In Demand For Personalized Medicine

An increase in demand for personalized medicine propelled the growth of the organoids market. Personalized medicine, also known as precision medicine or individualized medicine, is an approach to medical care that aims to tailor treatments and interventions to the specific characteristics of each patient. Organoids, with their ability to replicate individual patient characteristics, have become indispensable tools in tailoring medical treatments to specific genetic profiles and disease characteristics. This demand surge has elevated the significance and adoption of organoids in drug testing, disease modeling and precision medicine applications. For instance, in October 2022, the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system), estimated that more than 75,000 genetic testing products and 300 personalized medicines are on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, according to the Personalized Medicine Coalition (PMC), a US-based company that advocates for personalized medicine, personalized medicines were estimated to account for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, the increase in demand for personalized medicine supported the growth of the organoids market during the historic period.

Advancements In Life Science Research For The Production Of Specialized 3D Cell Models

Companies are focusing on advancements in life science research for the production of specialized 3D organoids, representing a substantial stride in biomedical advancement. These pioneering advancements entail crafting organoids that closely emulate the structural and functional intricacies of human organs, granting researchers an unparalleled understanding of disease mechanisms and drug reactions. For example, in February 2024, Cell Microsystems, a US-based biotechnology company that provides advanced tools for cell biology, announced a strategic partnership with OMNI Life Science (OLS), a Germany-based cell biology company. This collaboration endeavors to launch three groundbreaking products-CERO, CASY and TIGR-into the US and Canadian markets, advancing life science research in North America. The CERO 3D, a pioneering instrument, fosters an ideal cell culture environment for producing specialized 3D cell models, such as stem cells, spheroids, organoids and tissues.

The global organoids market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 17.50% of the total market in 2022.

Organoids Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global organoids market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for organoids? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The organoids market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider organoids market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by application, by end-use industries and by source.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the organoids market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by application, by end-use industries and by source in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Competitive Benchmarking -Briefs on the financials comparison between major players in the market.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for organoids providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Product: Hepatic Organoids; Colorectal Organoids; Intestinal Organoids; Other Organoids
• 2) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications
• 3) By End-Use Industries: Hospitals And Diagnostic Centers; Biopharmaceutical Companies; Academics And Research Institutes; Contract Research Organizations
• 4) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells
• Companies Mentioned: Thermo Fisher Scientific Inc.; Carl Zeiss AG; Corning Incorporated; Lonza Group Ltd.; STEMCELL Technologies Inc.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; organoids indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Organoids - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Organoids Market Definition And Segmentations
• 6.4 Market Segmentation By Product
  • 6.4.1 Hepatic Organoids
  • 6.4.2 Colorectal Organoids
  • 6.4.3 Intestinal Organoids
  • 6.4.4 Other Organoids
• 6.5 Market Segmentation By Application
  • 6.5.1 Developmental Biology
  • 6.5.2 Disease Pathology Of Infectious Disease
  • 6.5.3 Regenerative Medicine
  • 6.5.4 Drug Toxicity And Efficacy Testing
  • 6.5.5 Drug Discovery And Personalized Medicine
  • 6.5.6 Other Applications
• 6.6 Market Segmentation by End-Use Industries
  • 6.6.1 Hospitals And Diagnostic Centers
  • 6.6.2 Biopharmaceutical Companies
  • 6.6.3 Academics and Research Institutes
  • 6.6.4 Contract Research Organizations
• 6.7 Market Segmentation By Source
  • 6.7.1 Pluripotent Stem Cells
  • 6.7.2 Organ-Specific Adult Stem Cells

7 Major Market Trends

• 7.1 Focus On Organoid Solutions For Biotherapeutic Research And To Expand Solutions
• 7.2 Advancements In Life Science Research For The Production Of Specialized 3D Cell Models
• 7.3 Development Of Cardiac Organoids-Based Kits For Improved Cardiac Safety Testing
• 7.4 Strategic Partnerships And Collaborations To Advance Next-Generation Organoids Technology
• 7.5 Focus On Custom Organoid Line Services For High-Throughput Applications
• 7.6 Rising Adoption Of 3D Cell Culture Techniques To Expedite Organoid And Cell Harvesting

8 Organoids Market - Macro Economic Scenario

• 8.1 COVID-19 Impact On The Organoids Market
• 8.2 Impact Of The War In Ukraine On The Organoids Market
• 8.3 Impact Of High Inflation On The Organoids Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Organoids Market Segmentation

• 10.1 Global Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.4 Global Organoids Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Organoids Market, Regional and Country Analysis

• 11.1 Global Organoids Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Organoids Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia-Pacific Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.3 Asia-Pacific Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Organoids Market: Country Analysis
• 12.6 China Market
• 12.7 Summary
  • 12.7.1 Market Overview
  • 12.7.2 Country Information
  • 12.7.3 Market Information
  • 12.7.4 Background Information
  • 12.7.5 Government Initiatives
  • 12.7.6 Regulations
  • 12.7.7 Regulatory Bodies
  • 12.7.8 Major Associations
  • 12.7.9 Taxes Levied
  • 12.7.10 Corporate Tax Structure
  • 12.7.11 Investments
  • 12.7.12 Major Companies
• 12.8 China Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.9 China Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.10 China Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 India Market
• 12.12 India Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.14 India Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 Japan Market
• 12.16 Japan Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.18 Japan Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Australia Market
• 12.20 Australia Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.22 Australia Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Indonesia Market
• 12.24 Indonesia Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.26 Indonesia Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 South Korea Market
• 12.28 South Korea Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.30 South Korea Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate Tax Structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.3 Western Europe Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Organoids Market: Country Analysis
• 13.6 UK Market
• 13.7 UK Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.8 UK Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.12 Germany Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 France Market
• 13.15 France Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.16 France Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.20 Italy Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.24 Spain Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Investments
  • 14.1.12 Major Companies
• 14.2 Eastern Europe Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.3 Eastern Europe Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Organoids Market: Country Analysis
• 14.6 Russia Market
• 14.7 Russia Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.8 Russia Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.3 North America Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Organoids Market: Country Analysis
• 15.6 USA Market
• 15.7 Summary
  • 15.7.1 Market Overview
  • 15.7.2 Country Information
  • 15.7.3 Market Information
  • 15.7.4 Background Information
  • 15.7.5 Government Initiatives
  • 15.7.6 Regulations
  • 15.7.7 Regulatory Bodies
  • 15.7.8 Major Associations
  • 15.7.9 Taxes Levied
  • 15.7.10 Corporate Tax Structure
  • 15.7.11 Investments
  • 15.7.12 Major Companies
• 15.8 USA Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.9 USA Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.10 USA Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 Canada Market
• 15.12 Canada Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.14 Canada Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Investments
  • 16.1.12 Major Companies
• 16.2 South America Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.3 South America Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Organoids Market: Country Analysis
• 16.6 Brazil Market
• 16.7 Brazil Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.8 Brazil Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Investments
  • 17.1.12 Major Companies
• 17.2 Middle East Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.3 Middle East Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
  • 18.1.1 Market Overview
  • 18.1.2 Region Information
  • 18.1.3 Market Information
  • 18.1.4 Background Information
  • 18.1.5 Government Initiatives
  • 18.1.6 Regulations
  • 18.1.7 Regulatory Bodies
  • 18.1.8 Major Associations
  • 18.1.9 Taxes Levied
  • 18.1.10 Corporate Tax Structure
  • 18.1.11 Investments
  • 18.1.12 Major Companies
• 18.2 Africa Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.3 Africa Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Thermo Fisher Scientific Inc
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial performance
• 19.3 Carl Zeiss AG
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial performance
• 19.4 Corning Incorporated
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Performance
• 19.5 Lonza Group Ltd
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 STEMCELL Technologies Inc
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Axosim Acquired The Microbrain-Associated Assets Of Vyant Bio's Stemonix Subsidiary
• 22.2 Bruker Corporation Acquired Acquifer Imaging
• 22.3 Molecular Devices Acquired Cellesce
• 22.4 Crown Bioscience International Acquired OcellO

23 Opportunities And Strategies

• 23.1 Global Organoids Market In 2028 - Countries Offering Most New Opportunities
• 23.2 Global Organoids Market In 2028 - Segments Offering Most New Opportunities
• 23.3 Global Organoids Market In 2028 - Growth Strategies
  • 23.3.1 Market Trend Based Strategies
  • 23.3.2 Competitor Strategies

24 Organoids Market, Conclusions And Recommendations

• 24.1 Conclusions
• 24.2 Recommendations
  • 24.2.1 Product
  • 24.2.2 Place
  • 24.2.3 Price
  • 24.2.4 Promotion
  • 24.2.5 People

25 Appendix

• 25.1 Geographies Covered
• 25.2 Market Data Sources
• 25.3 Research Methodology
• 25.4 Currencies
• 25.5 The Business Research Company
• 25.6 Copyright and Disclaimer